Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Cambridge Technology Capital Limited investment portfolio
Cambridge Technology Capital Limited has made numerous investments in companies such as Lrg1, Cardiatec Biosciences, and Cambridge Nucleomics within the Healthcare & Life Sciences sector.
vc
Portfolio
3
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Cambridge Nucleomics Ltd Cambridge Nucleomics Ltd develops a rapid single‑molecule RNA‑counting platform that delivers high‑plex nucleic‑acid biomarker detection in a one‑pot reaction. Its technology is aimed at pharmaceutical companies, biotech firms and clinical researchers needing fast, accurate diagnostic and life‑science assays. | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-01-14 |
| Cardiatec Biosciences Ltd CardiaTec Biosciences applies artificial‑intelligence‑driven multi‑omics analysis of human cardiac tissue to discover and develop novel drug targets and therapies for cardiovascular disease. Its platform provides target‑discovery and personalised‑medicine capabilities to pharmaceutical and biotech companies developing next‑generation cardiovascular treatments. | Healthcare & Life Sciences | Oakham | Confirmed | 2026-06-09 |
Shareholding changes (2)
Sign up free to see when this investor has bought or sold shares.
Sign up freeArticles (1)
- Liquid Ventures I LP joins Cardiatec Biosciences as LQD Ventures exits10 Jun 2026Cardiatec Biosciences